926
Participants
Start Date
September 30, 2020
Primary Completion Date
August 31, 2025
Study Completion Date
December 31, 2026
High-dose rifampicin
30mg/kg
Isoniazid
300mg
Pyrazinamide
20-30mg/kg
Ethambutol
15-20mg/kg
Rifampicin
10mg/kg
Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine, Seoul
Collaborators (1)
Chonnam National University Hospital
OTHER
National Medical Center, Seoul
OTHER
Pusan National University Hospital
OTHER
Pusan National University Yangsan Hospital
OTHER
Seoul National University Bundang Hospital
OTHER
SMG-SNU Boramae Medical Center
OTHER
Severance Hospital
OTHER
Korean Institute of Tuberculosis
OTHER
International Tuberculosis Research Center
OTHER
Korean Center for Disease Control and Prevention
OTHER_GOV
Seoul National University Hospital
OTHER